Proud to share the SS25 UCLA Radiation Oncology Journal.
This issue features Francesco Clemente. Richard Deming and his book, This Exquisite Loneliness. Leanne Ford as our Featured Designer. And Yale Younger, Richard Siken as our Featured Poet.
tinyurl.com/UCLA-RO
Chief of Thoracic Oncology in the Department of Radiation Oncology, @DrewMoghanaki, on how "treatment decisions can also be shaped by fatalism—the lingering belief that metastatic lung cancer is hopeless."
Congratulations to UCLA Radiation Oncology's @JieDengMDPhD on her Holman project.
Read More Here: uclahealth.org/news/release/…
UCLA Rad. Onc. Co-Authors include Dr. Dorthe Schaue and Dr. Vish Reddy
UCLA Radiation Oncology's Dr. @DrewMoghanaki emphasizes the national importance of lung cancer screening to the @nytimes in reference to a recent JAMA publication from scientists at the American Cancer Society.
Read the piece here: archive.is/IHOyy
#LungCancer screening saves lives — but current criteria miss nearly half of future cases. Dr. Drew Moghanaki explains why change is needed. More from @nytimes: nyti.ms/487lYco
A new @JAMAOnc study co-led by @AmarUKishan suggests shorter courses of androgen deprivation therapy may reduce risks while maintaining effective cancer control. bit.ly/487Aelm
@UCLA Rad Onc residents locking in on their research at #ASTRO2025 🤩 so proud!
Highlights from Mon feat. PGY5 Travis Courtney, PGY3s Nic Nelson and Mimi Lane, and former resident (now @StanfordRadOnc faculty) Beth Neilsen.
New 4-year results from the SCIMITAR trial, led by @AmarUKishan & @MSteinbergMD and published in @EUplatinum, show that SBRT after prostate surgery is safe, effective & comparable to standard radiation.
bit.ly/4gOisrg
Don't miss @TrudyWuMD at #ASTRO25 moderating a panel on using digital tools to make cancer education more understandable. Experts and a patient advocate share strategies, videos & resources to help empower patients in their cancer journey.
Learn more: bit.ly/46K1Cq5
Just in from #ASTRO25: @AmarUKishan & @CalaisJeremie report adding PSMA-targeted radioligand therapy before SBRT more than doubled progression-free survival in men with recurrent prostate cancer (17.6 vs 7.4 months), delaying the need for hormone therapy. bit.ly/4mAuZzV
Don’t miss Dr. Jonathan Massachi at #ASTRO25 sharing MIRAGE trial results on sexual function in men receiving SBRT for prostate cancer, comparing CT-guided vs MRI-guided treatment.
Learn more: bit.ly/3KcuNtc
This morning at #ASTRO25, Dr. Travis Courtney will discuss research that compares the side effects of standard high-dose MRgSBRT with an adaptive dose-painted approach that boosts radiation to tumor areas while sparing surrounding tissue.
Learn more: bit.ly/3KdBpHO
Today, Dr. Miriam Lane will present new findings at #ASTRO25 on postoperative SBRT for patients with newly diagnosed or recurrent head and neck cancer.
Learn more: bit.ly/42zGxw9
Today at #ASTRO25: Dr. Daniel Low, a UCLA professor of radiation oncology, will present results from the first large study of 5DCT, a new imaging technique that enhances scans for lung cancer patients with irregular breathing patterns.
Learn more: bit.ly/46ccZqL